{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T12:27:31Z","timestamp":1763296051924,"version":"3.41.2"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UC-Davis Burden Family Gift Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Severe coccidioidomycosis presenting with respiratory failure is an uncommon manifestation of disease. Current knowledge of this condition is limited to case reports and small case series.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective multicenter review of patients with coccidioidomycosis-associated acute respiratory distress syndrome (CA-ARDS) was conducted. It assessed clinical and laboratory variables at the time of presentation, reviewed the treatment course, and compared this cohort with a national database of patients with noncoccidioidomycosis ARDS. Survivors and nonsurvivors of coccidioidomycosis were also compared to determine prognostic factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In this study, CA-ARDS (n = 54) was most common in males, those of Hispanic ethnicity, and those with concurrent diabetes mellitus. As compared with the PETAL network database (Prevention and Early Treatment of Acute Lung Injury; n = 1006), patients with coccidioidomycosis were younger, had fewer comorbid conditions, and were less acidemic. The 90-day mortality was 15.4% for patients with coccidioidomycosis, as opposed to 42.6% (P &amp;lt; .0001) for patients with noncoccidioidomycosis ARDS. Patients with coccidioidomycosis who died, as compared with those who survived, were older, had higher APACHE II scores (Acute Physiology and Chronic Health Evaluation), and did not receive corticosteroid therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>CA-ARDS is an uncommon but morbid manifestation of infection. When compared with a national database, the overall mortality appears favorable vs other causes of ARDS. Patients with CA-ARDS had a low overall mortality but required prolonged antifungal therapy. The utility of corticosteroids in this condition remains unconfirmed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofad679","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T02:05:41Z","timestamp":1708135541000},"source":"Crossref","is-referenced-by-count":4,"title":["Hypoxemic Respiratory Failure and Coccidioidomycosis-Associated Acute Respiratory Distress Syndrome"],"prefix":"10.1093","volume":"11","author":[{"given":"Arash","family":"Heidari","sequence":"first","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California Los Angeles , Bakersfield, California , USA"},{"name":"Dignity Health, Bakersfield Memorial Hospital , Bakersfield, California , USA"},{"name":"Valley Fever Institute , Bakersfield, California , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simmer","family":"Kaur","sequence":"additional","affiliation":[{"name":"Valley Fever Institute , Bakersfield, California , USA"},{"name":"Division of Infectious Diseases, Department of Internal Medicine, Kern Medical , Bakersfield, California , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Skyler J","family":"Pearson","sequence":"additional","affiliation":[{"name":"University of California\u2013Davis Medical Center , Sacramento, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augustine","family":"Munoz","sequence":"additional","affiliation":[{"name":"Valley Fever Institute , Bakersfield, California , USA"},{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kern Medical , Bakersfield, California , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harleen","family":"Sandhu","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Kern Medical , Bakersfield, California , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gursimran","family":"Mann","sequence":"additional","affiliation":[{"name":"University of California\u2013Davis Medical Center , Sacramento, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schivo","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, UC Davis Lung Center, University of California Davis Medical Center , Sacramento, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir A","family":"Zeki","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, UC Davis Lung Center, University of California Davis Medical Center , Sacramento, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek J","family":"Bays","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, University of California Davis Medical Center , Sacramento, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Machelle","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, University of California\u2013 Davis, Davis, California , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy E","family":"Albertson","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, UC Davis Lung Center, University of California Davis Medical Center , Sacramento, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Royce","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California Los Angeles , Bakersfield, California , USA"},{"name":"Valley Fever Institute , Bakersfield, California , USA"},{"name":"Division of Infectious Diseases, Department of Internal Medicine, Kern Medical , Bakersfield, California , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"George R","family":"Thompson","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, UC Davis Lung Center, University of California Davis Medical Center , Sacramento, CA, USA"},{"name":"Department of Medical Microbiology and Immunology , University of California\u2013Davis Medical Center, Davis, California , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"key":"2024021702053054400_ofad679-B1","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2024021702053054400_ofad679-B2","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/S1473-3099(21)00191-2","article-title":"Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology","volume":"21","author":"Thompson","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2024021702053054400_ofad679-B3","first-page":"1060","article-title":"Treatment for early, uncomplicated coccidioidomycosis: what is success?","volume":"69","author":"Galgiani","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024021702053054400_ofad679-B4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"issue":"6, pt 1","key":"2024021702053054400_ofad679-B5","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1164\/ajrccm.152.6.8520742","article-title":"Identification of patients with acute lung injury: predictors of mortality","volume":"152","author":"Doyle","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2024021702053054400_ofad679-B6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.idc.2021.03.010","article-title":"Coccidioidomycosis","volume":"35","author":"Bays","year":"2021","journal-title":"Infect Dis Clin North Am"},{"key":"2024021702053054400_ofad679-B7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.idc.2015.10.008","article-title":"Coccidioidomycosis","volume":"30","author":"Stockamp","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"2024021702053054400_ofad679-B8","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1055\/s-0031-1295723","article-title":"Pulmonary coccidioidomycosis","volume":"32","author":"Thompson","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"2024021702053054400_ofad679-B9","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/00003246-200208000-00037","article-title":"Adjunctive corticosteroids therapy in acute respiratory distress syndrome owing to disseminated coccidioidomycosis","volume":"30","author":"Shibli","year":"2002","journal-title":"Crit Care Med"},{"key":"2024021702053054400_ofad679-B10","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024021702053054400_ofad679-B11","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00134-012-2682-1","article-title":"The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material","volume":"38","author":"Ferguson","year":"2012","journal-title":"Intensive Care Med"},{"key":"2024021702053054400_ofad679-B12","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1056\/NEJMoa1901686","article-title":"Early neuromuscular blockade in the acute respiratory distress syndrome","volume":"380","author":"National Heart, Lung, and Blood Institute PETAL Clinical Trials Network","year":"2019","journal-title":"N Engl J Med"},{"key":"2024021702053054400_ofad679-B13","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3201\/eid2006.131842","article-title":"Characteristics of patients with mild to moderate primary pulmonary coccidioidomycosis","volume":"20","author":"Blair","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2024021702053054400_ofad679-B14","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJM199011223232104","article-title":"A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome","volume":"323","author":"Bozzette","year":"1990","journal-title":"N Engl J Med"},{"key":"2024021702053054400_ofad679-B15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1378\/chest.117.2.404","article-title":"Miliary coccidioidomycosis in the immunocompetent","volume":"117","author":"Arsura","year":"2000","journal-title":"Chest"},{"key":"2024021702053054400_ofad679-B16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"suppl 1","key":"2024021702053054400_ofad679-B17","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1093\/mmy\/myy095","article-title":"Update on the epidemiology of coccidioidomycosis in the United States","volume":"57","author":"McCotter","year":"2019","journal-title":"Med Mycol"},{"key":"2024021702053054400_ofad679-B18","doi-asserted-by":"crossref","first-page":"ofab543","DOI":"10.1093\/ofid\/ofab543","article-title":"Sex differences in susceptibility to coccidioidomycosis","volume":"9","author":"McHardy","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2024021702053054400_ofad679-B19","doi-asserted-by":"crossref","first-page":"e3538","DOI":"10.1097\/MD.0000000000003538","article-title":"Management and outcomes of acute respiratory distress syndrome caused by blastomycosis: a retrospective case series","volume":"95","author":"Schwartz","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2024021702053054400_ofad679-B20","doi-asserted-by":"crossref","first-page":"e15095","DOI":"10.1097\/MD.0000000000015095","article-title":"The effect of diabetes on the risk and mortality of acute lung injury\/acute respiratory distress syndrome: a meta-analysis","volume":"98","author":"Ji","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2024021702053054400_ofad679-B21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13054-018-2079-9","article-title":"Immunocompromised patients with acute respiratory distress syndrome: secondary analysis of the LUNG SAFE database","volume":"22","author":"Cortegiani","year":"2018","journal-title":"Crit Care"},{"key":"2024021702053054400_ofad679-B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-8278(91)90900-V","article-title":"Fungal infection: a common, unrecognised complication of acute liver failure","volume":"12","author":"Rolando","year":"1991","journal-title":"J Hepatol"},{"key":"2024021702053054400_ofad679-B23","doi-asserted-by":"crossref","first-page":"ofv197","DOI":"10.1093\/ofid\/ofv197","article-title":"End-stage liver disease is a strong predictor of early mortality in cryptococcosis","volume":"3","author":"Spec","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2024021702053054400_ofad679-B24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/jof9030305","article-title":"Case series of end-stage liver disease patients with severe coccidioidomycosis","volume":"9","author":"Ho","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"2024021702053054400_ofad679-B25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/s-2008-1063855","article-title":"Pulmonary coccidioidomycosis","volume":"29","author":"Spinello","year":"2008","journal-title":"Semin Respir Crit Care Med"},{"key":"2024021702053054400_ofad679-B26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1513\/AnnalsATS.201308-286FR","article-title":"Update on the diagnosis of pulmonary coccidioidomycosis","volume":"11","author":"Malo","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"2024021702053054400_ofad679-B27","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1093\/cid\/cir466","article-title":"Early treatment with fluconazole may abrogate the development of IgG antibodies in coccidioidomycosis","volume":"53","author":"Thompson","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2024021702053054400_ofad679-B28","doi-asserted-by":"crossref","first-page":"e01318-18","DOI":"10.1128\/JCM.01318-18","article-title":"Coccidioidomycosis complement fixation titer trends in the age of antifungals","volume":"56","author":"McHardy","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2024021702053054400_ofad679-B29","doi-asserted-by":"crossref","first-page":"e0158122","DOI":"10.1128\/jcm.01581-22","article-title":"Review of clinical and laboratory diagnostics for coccidioidomycosis","volume":"61","author":"McHardy","year":"2023","journal-title":"J Clin Microbiol"},{"key":"2024021702053054400_ofad679-B30","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201703-0548ST","article-title":"An official American Thoracic Society\/European Society of Intensive Care Medicine\/Society of Critical Care Medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome","volume":"195","author":"Fan","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 1","key":"2024021702053054400_ofad679-B31","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1093\/mmy\/myy029","article-title":"Current concepts and future directions in the pharmacology and treatment of coccidioidomycosis","volume":"57","author":"Thompson","year":"2019","journal-title":"Med Mycol"},{"key":"2024021702053054400_ofad679-B32","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1378\/chest.07-2778","article-title":"Corticosteroids for blastomycosis-induced ARDS: a report of two patients and review of the literature","volume":"133","author":"Lahm","year":"2008","journal-title":"Chest"},{"key":"2024021702053054400_ofad679-B33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1378\/chest.66.2.158","article-title":"Acute histoplasmosis presenting as the adult respiratory distress syndrome","volume":"66","author":"Wynne","year":"1974","journal-title":"Chest"},{"key":"2024021702053054400_ofad679-B34","first-page":"103","article-title":"Histoplasmosis presenting as acute respiratory distress syndrome after exposure to bat feces in a home basement","volume":"4","author":"Pecanha Martins","year":"2000","journal-title":"Braz J Infect Dis"},{"key":"2024021702053054400_ofad679-B35","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/00007611-198105000-00007","article-title":"Acute pulmonary histoplasmosis presenting as adult respiratory distress syndrome: effect of therapy on clinical and laboratory features","volume":"74","author":"Kataria","year":"1981","journal-title":"South Med J"},{"key":"2024021702053054400_ofad679-B36","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/13693780903330563","article-title":"Fatal acute respiratory distress syndrome in a patient with paracoccidioidomycosis: first case report","volume":"48","author":"Benard","year":"2010","journal-title":"Med Mycol"},{"key":"2024021702053054400_ofad679-B37","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1164\/rccm.201510-1975IM","article-title":"Acute respiratory distress syndrome in lung paracoccidioidomycosis","volume":"193","author":"Dias","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2024021702053054400_ofad679-B38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.amjmed.2018.09.020","article-title":"Corticosteroids in the management of severe coccidioidomycosis","volume":"132","author":"Chang","year":"2019","journal-title":"Am J Med"},{"key":"2024021702053054400_ofad679-B39","first-page":"CD006150","article-title":"Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection","volume":"2015","author":"Ewald","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2024021702053054400_ofad679-B40","first-page":"727","article-title":"Coccidioidomycosis: part II","volume":"117","author":"Drutz","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"2024021702053054400_ofad679-B41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/MCC.0000000000000571","article-title":"Phenotypes in acute respiratory distress syndrome: moving towards precision medicine","volume":"25","author":"Sinha","year":"2019","journal-title":"Curr Opin Crit Care"},{"key":"2024021702053054400_ofad679-B42","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","article-title":"Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials","volume":"2","author":"Calfee","year":"2014","journal-title":"Lancet Respir Med"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/2\/ofad679\/56672569\/ofad679.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/2\/ofad679\/56672569\/ofad679.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T02:06:12Z","timestamp":1708135572000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofad679\/7604242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad679","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2024,2,1]]},"article-number":"ofad679"}}